PPT-Global Action Plan to combat antimicrobial resistance

survivors Penicillin Untreated Days Penicillin increased the chance of survival from 10 to 90 Patients with pneumonia and bacteria in the blood Adapted from Austrian et al Ann Int Med 1964 . % . survivors. Penicillin. Untreated. Days. Penicillin increased the chance of survival from 10% to 90%. Patients with. pneumonia . and bacteria . in the blood. Adapted from Austrian . et al.. Ann. Int. Med 1964; . What are antibiotics?. Definition: chemicals produced by one microorganism to kill or inhibit the growth of other microorganisms. Now included the semi-synthetic antibiotics. Effective against bacteria. Regulations. An Environment of Change. Brian Lubbers, DVM, PhD, . DACVCP. Director of Clinical Microbiology. Changing Regulations. Cephalosporin . Extralabel. Use Restriction. FDA Guidance 209. FDA Guidance 213. . Dr Andrea Ammon, ECDC Director, . 27 June 2017, European Parliament. 0. 200. 400. 600. 800. 1000. 1900. 1920. 1940. 1960. 1980. 2000. 1918. Influenza pandemic. 1924. Plague: last human-to-human transmission. a pharmaceutical industry perspective. 17. th. November 2018. Dr Bryan Deane. Dept of Research, Medical & Innovation . Introduction – the ABPI; the biopharmaceutical industry. AMR: the issue. Global . Overview: Evolving challenge. Nordic Health Summit. Oslo . 10 May 2016. Keiji . Fukuda . Where are we. ?. Why?. Where do we want to . go?. How?. I. n 20. th. Century, deaths from infections dropped (United States pattern). Ireland. Quarter 1-4 2017. 20. th. June 2018. KEY POINTS, 2017 (General). Increasing numbers of invasive infections in recent . years due to the following pathogens. : . K. . pneumonaie. , . P. . aeruginosa, S. . % . survivors. Penicillin. Untreated. Days. Penicillin increased the chance of survival from 10% to 90%. Patients with. pneumonia . and bacteria . in the blood. Adapted from Austrian . et al.. Ann. Int. Med 1964; . Ireland. Quarter 1-4 2017. 20. th. June 2018. KEY POINTS, 2017 (General). Increasing numbers of invasive infections in recent . years due to the following pathogens. : . K. . pneumonaie. , . P. . aeruginosa, S. . (2011 – 2020). &. Global action plan on AMR . (2015). Dr Danilo Lo Fo . Wong. Programme Manager AMR. WHO Regional Office for Europe. WHO efforts on antimicrobial resistance. 2014. 2015. 2001. 2003. Introduction This booklet contains the Ouagadougou Action Plan to Combat Trafficking in Human Beings Especially Women and Children The Ouagadougou Action Plan was adopted by Ministers for Foreign Af Therapy. The development of antimicrobial drugs represents one of the most important advances in therapeutics, both in the control or cure of serious infections and in the prevention and treatment of infectious complications of other therapeutic modalities such as cancer chemotherapy, immunosuppression, and surgery.. CC – 14/ UNIT - 7. Azidothymidine Antibiotic Resistance. Zidovudine (AZT). A synthetic pyrimidine (thymidine) analogue. AZT is converted to its triphosphate form by cellular thymidine kinase. It binds preferentially to HIV – reverse transcriptase resulting in chain termination. . 1. 1. Antibacterial resistance in ophthalmic infections: a multi-centre analysis across UK care settings//BMC Infectious Diseases.- volume 19, Article number: 768 (2019) . Educational MODULE. November 2020.